Significant and sustained improvement in the severity of itch at nearly all timepoints measured
~68% of patients achieved WI-NRS Success at Week 8*1,3
†P<0.0001 vs vehicle.
‡P<0.001 vs vehicle.
*WI-NRS Success defined as a ≥4-point improvement for patients with a baseline score ≥4.
WI-NRS scale: 0 (no itch) to 10 (worst imaginable itch).
More than 2 out of 3 patients achieved a ≥4-point improvement in itch at Week 8
ITCH IS THE MOST BOTHERSOME and frequently reported symptom of psoriasis, according to a 2012 population-based survey of over 2,700 patients with plaque psoriasis in North America and Europe.4